Icam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation.
Lysozyme dextran nanogels (NG) have great potential in vitro as a drug delivery platform, combining simple chemistry with rapid uptake and cargo release in target cells with "stealth" properties and low toxicity. In this work, we study for the first time the potential of targeted NG as a d...
Main Authors: | M Carme Coll Ferrer, Vladimir V Shuvaev, Blaine J Zern, Russell J Composto, Vladimir R Muzykantov, David M Eckmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4096597?pdf=render |
Similar Items
-
Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury
by: Evan M. Lutton, et al.
Published: (2017-06-01) -
Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
by: Colin F Greineder, et al.
Published: (2013-01-01) -
ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
by: Deborah L. W. Chong, et al.
Published: (2021-08-01) -
Combination Therapy of Wuweizi (Schisandrae Chinensis Fructus) and Dexamethasone Alleviated Dexamethasone-Induced Glucocorticoid Osteoporosis in Rats with Idiopathic Pulmonary Fibrosis
by: Zinan Qin, et al.
Published: (2020-01-01) -
Strain-rate Dependence of Elastic Modulus Reveals Silver Nanoparticle Induced Cytotoxicity
by: Matthew Alexander Caporizzo, et al.
Published: (2015-09-01)